Incidence and clinical management of paediatric emergency presentations of anaphylaxis in Alberta
Paediatrics & Child Health · 20.07.2026 · 31 (5) · 477-486
DOI: 10.1093/pch/pxag026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Paediatrics & Child Health, online erschienen am 17.04.2026. Verfasst von Nana Owusu M Essel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Scientific Director’s Grant, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objectives
Anaphylaxis represents a growing burden on emergency services worldwide; however, long-term paediatric trends are poorly understood. This study examined the incidence, clinical features, management, and outcomes of paediatric emergency department (ED) presentations for anaphylaxis in a western Canadian province and forecasted future visit rates.
Methods
This population-based retrospective cohort study used linked administrative health data for all paediatric (<18 years) ED presentations for anaphylaxis in Alberta, between 2004 and 2024. Temporal trends were assessed with time-series models and logistic regression identified factors for hospitalization.
Results
Over the study period, 11,012 anaphylaxis visits were identified (median age 8 years [IQR, 3 to 14]; 57.9% male). Food was the most common trigger (71.1%), although nearly 1 in 4 had no clear cause. The incidence of anaphylaxis ED visits quadrupled, from ∼25 per 100,000 in 2004/05 to 113 per 100,000 in 2023/24, with forecasts projecting a continued rise. Epinephrine was administered in 41.9% of ED encounters and 19.5% of ambulance transports. Hospitalization was infrequent (3.7%); however, it was significantly associated with higher triage acuity (aOR = 1.45; 95% CI: 1.10 to 1.90), higher comorbidity scores (aOR = 1.31; 95% CI: 1.17 to 1.48), and drug-related triggers (aOR = 2.45; 95% CI: 1.60 to 3.75). Females had a significantly higher and earlier risk of 30-day ED revisit for anaphylaxis (P < 0.001).
Conclusion
Paediatric presentations to Alberta EDs for anaphylaxis have quadrupled and are forecasted to continue increasing. First-line epinephrine is severely underutilized, especially prehospital. Further studies are needed to identify factors underlying the observed sex differences and upward trajectories and bridge potential system and policy gaps in “Epi-Care.”
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Faculty of Medicine & Dentistry, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
- SPOR SUPPORT Unit, Alberta Health Services (AHS), Edmonton, Alberta, Canada.
- School of Public Health, College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Nana Owusu M Essel
Förderung
- Scientific Director’s Grant
- Canadian Institutes of Health Research
Zitieren
APA
Essel, N. O. M., Nathoo, H., Yang, E. H., & Rowe, B. H. (2026). Incidence and clinical management of paediatric emergency presentations of anaphylaxis in Alberta. Paediatrics & Child Health, 31(5), 477-486. https://doi.org/10.1093/pch/pxag026
Vancouver
Essel NOM, Nathoo H, Yang EH, Rowe BH. Incidence and clinical management of paediatric emergency presentations of anaphylaxis in Alberta. Paediatrics & Child Health. 2026;31(5):477-486. doi:10.1093/pch/pxag026
BibTeX
@article{Essel2026,
author = {Essel, Nana Owusu M and Nathoo, Hafeez and Yang, Esther H and Rowe, Brian H},
title = {Incidence and clinical management of paediatric emergency presentations of anaphylaxis in Alberta},
journal = {Paediatrics & Child Health},
year = {2026},
volume = {31},
number = {5},
pages = {477--486},
doi = {10.1093/pch/pxag026}
}
EUVIMED